At 24 h after transfection, compared with the blank, miR-126 inhibitor NC and miR-126 inhibitors + si-EGFL7 group, the proliferation of HCC cells was increased in the miR-126 inhibitors group and decreased in the miR-126 mimics and si-EGFL7 groups (all P < 0.05). Here, EGFL7 is linked to hepatocellular carcinoma.